DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Entecavir- Drug Insight and Market Forecast – 2030
US$ 2,750.00
This report can be delivered to the clients within 24 Hours “Entecavir- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for th...
October 2020
50 pages
Epclusa- Drug Insight and Market Forecast – 2030
US$ 2,750.00
This report can be delivered to the clients within 24 Hours “Epclusa- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the...
October 2020
50 pages
Harvoni- Drug Insight and Market Forecast – 2030
US$ 2,750.00
This report can be delivered to the clients within 24 Hours “Harvoni- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the...
October 2020
50 pages
Mavyret- Drug Insight and Market Forecast – 2030
US$ 2,750.00
This report can be delivered to the clients within 24 Hours “Mavyret- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the...
October 2020
50 pages
Upadacitinib- Drug Insight and Market Forecast – 2030
US$ 2,750.00
This report can be delivered to the clients within 24 Hours “Upadacitinib- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for...
October 2020
50 pages
Cutaneous Lupus Erythematosus – Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cutaneous Lupus Erythematosus The report also ...
September 2020
60 pages
Fragile X Syndrome – Pipeline Insight, 2020
US$ 2,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Fragile X Syndrome The report also ...
September 2020
115 pages
Hereditary angioedema – Pipeline Insight, 2020
US$ 2,500.00
... clients within 48 Hours 'Hereditary Angioedema - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hereditary Angioedema development. The report provides ...
September 2020
100 pages
Dilated Cardiomyopathy – Pipeline Insight, 2020
US$ 1,500.00
... clients within 48 Hours 'Dilated Cardiomyopathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dilated Cardiomyopathy development. The report provides ...
September 2020
67 pages
Exocrine Pancreatic Insufficiency (EPI) – Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Exocrine Pancreatic Insufficiency The report also ...
September 2020
71 pages
Pompe Disease – Pipeline Insight, 2020
US$ 2,500.00
... clients within 48 Hours 'Pompe Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pompe Disease development. The report provides ...
September 2020
90 pages
C-Raf Kinase Inhibitor– Pipeline Insight, 2020
US$ 1,500.00
... drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “C-Raf Kinase Inhibitor The report assesses the active C-Raf Kinase ...
September 2020
60 pages
Lennox Gastaut Syndrome – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Lennox Gastaut Syndrome – Pipeline Insight, 2020,” report provides comprehensive insights about 15+ companies and 15+ pip...
September 2020
60 pages
Postpartum Depression – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Postpartum Depression – Pipeline Insight, 2020,” report provides comprehensive insights about 2+ companies and 2+ pipelin...
September 2020
55 pages
Prurigo nodularis – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Prurigo nodularis – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+ pipeline dr...
September 2020
60 pages
AT845 - Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “AT845 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...
September 2020
50 pages
BLU 782- Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BLU 782- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
September 2020
50 pages
EB 101- Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “EB 101- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...
September 2020
50 pages
FCX-007- Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “FCX-007- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
September 2020
50 pages
FLT190 - Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “FLT190 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
September 2020
50 pages
HC 1119- Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “HC 1119- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
September 2020
50 pages
KB 105 - Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “KB 105 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
September 2020
50 pages
Lenti-D- Emerging Drug Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “Lenti-D- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
September 2020
50 pages
